文献
J-GLOBAL ID:202002212785045565
整理番号:20A2045279
日本における現実世界設定の進行性非扁平上皮非小細胞肺癌患者における個別化第一選択療法のためのバイオマーカー試験:後ろ向き,多施設,観察研究(BRAVE研究)【JST・京大機械翻訳】
Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)
著者 (9件):
Shimizu Junichi
(Department of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan)
,
Masago Katsuhiro
(Department of Pathology and Molecular Diagnosis, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan)
,
Saito Haruhiro
(Department of Thoracic Oncology, Kanagawa Cancer Center, Asahi-ku, Yokohama, Japan)
,
Nishino Kazumi
(Department of Thoracic Oncology, Osaka International Cancer Institute, Chuo-ku, Osaka, Japan)
,
Kurata Takayasu
(Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Osaka, Japan)
,
Itoh Yohji
(Statistics Group, AstraZeneca, Kita-ku, Osaka, Japan)
,
Yoshimura Yoko
(Medical Department, AstraZeneca, Kita-ku, Osaka, Japan)
,
Yabuki Yutaka
(Medical Department, AstraZeneca, Kita-ku, Osaka, Japan)
,
Dosaka-Akita Hirotoshi
(Department of Medical Oncology, Faculty of Medicine & Graduate School of Medicine, Hokkaido University, Sapporo, Japan)
資料名:
Therapeutic Advances in Medical Oncology
(Therapeutic Advances in Medical Oncology)
巻:
12
ページ:
1758835920904522
発行年:
2020年
JST資料番号:
W5408A
ISSN:
1758-8340
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)